News in the Life Sciences Industry

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chronic... Read more ››

STOCKHOLM, Dec. 23, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced the full recruitment of all 200 patients required for Part A of the company's pivotal Phase 3 study NefIgArd. Top line readout of Part A of the study is expected in Q4 2020.

STOCKHOLM, Dec. 23, 2019 /PRNewswire/ -- Carbiotix (publ) ("Carbiotix") announces today that the company has signed a collaboration agreement with the Department of Medicine at the University of Verona, Italy, to carry out a research study during H1 2020 in the area of neuroinflammation using... Read more ››

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- BioInvent International AB ("BioInvent" or the "Company") (OMXS: BINV) today announces that Pfizer Inc. ("Pfizer") (NYSE: PFE) has selected the second target under the companies' cancer immunotherapy research collaboration and license Read more ››

STOCKHOLM, Dec. 21, 2019 /PRNewswire/ -- Dova Pharmaceuticals, Inc., a wholly owned subsidiary of Swedish Orphan Biovitrum AB (publ) (Sobi(TM)) has been granted Orphan Drug Designation([1]) (ODD) by the US Food and Drug Administration (FDA) for avatrombopag for the potential treament of Chemotherapy-Induced... Read more ››

LUND, Sweden, Dec. 20, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chronic... Read more ››

STOCKHOLM, Dec. 20, 2019 /PRNewswire/ -- Diamyd Medical announced today, when all 12 patients have been followed throughout the 30-month period in the open-label trial DIAGNODE-1, that the patients show on average a positive clinical course with a near normal long-term blood sugar and a low... Read more ››

GOTHENBURG, Sweden, Dec. 20, 2019 /PRNewswire/ -- Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL). A patent covering the Active Pharmaceutical Ingredient (API), arfolitixorin hemisulfate, in Isofol's drug candidate has been approved by the the Japanense Patent Office. The Patent... Read more ››

STOCKHOLM, Dec. 20, 2019 /PRNewswire/ -- AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with a focus on Alzheimer's disease, announces that it has obtained the necessary... Read more ››

STOCKHOLM, Dec. 19, 2019 /PRNewswire/ -- IRRAS, a global healthcare company with a comprehensive portfolio of innovative products for neurocritical care, announced today that it received CE Mark approval for its IRRAflow(®) catheter. This CE Mark complements the two CE Marks previously... Read more ››

GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems... Read more ››